Pharmaceutical industry makes progress in cutting-edge R&D for neglected diseases
IFPMA – 19 February 2015
:: Report shows 13% annual increase of pharmaceutical R&D projects to develop treatments to eliminate and control neglected diseases. In 2014, 186 projects were underway.
:: 38 vaccines and treatments currently undergo clinical trials, 10 of which are in final stages. Projects include potential treatments and vaccines for TB, sleeping sickness, malaria, dengue, Chagas, schistosomiasis, intestinal worms and Ebola.
:: Pharmaceutical industry also works with WHO and other partners to implement 40 programs to support health system capacity-strengthening and donations.